Handelsbanken Fonder’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.18M | Sell |
66,800
-7,500
| -10% | -$1.03M | 0.03% | 359 |
|
|
2025
Q1 | $13.4M | Sell |
74,300
-11,000
| -13% | -$1.98M | 0.06% | 294 |
|
|
2024
Q4 | $13.4M | Sell |
85,300
-9,400
| -10% | -$1.47M | 0.05% | 311 |
|
|
2024
Q3 | $17.2M | Sell |
94,700
-11,800
| -11% | -$2.15M | 0.07% | 259 |
|
|
2024
Q2 | $19.6M | Buy |
106,500
+1,300
| +1% | +$239K | 0.09% | 211 |
|
|
2024
Q1 | $18.7M | Sell |
105,200
-18,000
| -15% | -$3.2M | 0.08% | 233 |
|
|
2023
Q4 | $15.3M | Buy |
123,200
+10,400
| +9% | +$1.29M | 0.07% | 254 |
|
|
2023
Q3 | $13.1M | Buy |
112,800
+5,600
| +5% | +$650K | 0.07% | 270 |
|
|
2023
Q2 | $12.6M | Buy |
107,200
+2,000
| +2% | +$235K | 0.07% | 295 |
|
|
2023
Q1 | $8.42M | Hold |
105,200
| – | – | 0.05% | 350 |
|
|
2022
Q4 | $8.33M | Buy |
105,200
+300
| +0.3% | +$23.8K | 0.05% | 347 |
|
|
2022
Q3 | $7.31M | Sell |
104,900
-8,000
| -7% | -$558K | 0.05% | 339 |
|
|
2022
Q2 | $7.41M | Buy |
112,900
+2,900
| +3% | +$190K | 0.05% | 349 |
|
|
2022
Q1 | $7.32M | Buy |
110,000
+20,000
| +22% | +$1.33M | 0.04% | 392 |
|
|
2021
Q4 | $6.3M | Hold |
90,000
| – | – | 0.03% | 445 |
|
|
2021
Q3 | $4.7M | Hold |
90,000
| – | – | 0.02% | 483 |
|
|
2021
Q2 | $6.12M | Hold |
90,000
| – | – | 0.03% | 450 |
|
|
2021
Q1 | $6.93M | Hold |
90,000
| – | – | 0.04% | 369 |
|
|
2020
Q4 | $5.4M | Hold |
90,000
| – | – | 0.03% | 399 |
|
|
2020
Q3 | $3.87M | Hold |
90,000
| – | – | 0.03% | 410 |
|
|
2020
Q2 | $3.73M | Buy |
+90,000
| New | +$3.73M | 0.03% | 400 |
|